Bovalto Ibraxion

Withdrawn

This medicine's authorisation has been withdrawn

infectious bovine rhinotracheitis vaccine (inactivated)

Overview

The marketing authorisation for Bovalto Ibraxion has been withdrawn at the request of the marketing authorisation holder.

Bovalto Ibraxion : EPAR - Summary for the public

Product information

Bovalto Ibraxion : EPAR - Product Information

Bovalto Ibraxion : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Bovalto Ibraxion
• Active substance:
  inactivated IBR virus
• International non-proprietary name (INN) or common name:
  infectious bovine rhinotracheitis vaccine (inactivated)
• Species:
  Cattle
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QI02AA03

Pharmacotherapeutic group

Immunologicals for Bovidae

Therapeutic indication

Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
The onset of immunity is 14 days and the duration of immunity is 6 months.

Authorisation details

• EMA product number:
  EMEA/V/C/000051
• Marketing authorisation holder:
  Merial

  29 Avenue Tony Garnier; 69007 Lyon; France

• Marketing authorisation issued:
  09/03/2000
• Revision:
  10

Assessment history

Changes since initial authorisation of medicine

Bovalto Ibraxion : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Bovalto Ibraxion : EPAR - Procedural steps taken before authorisation

Bovalto Ibraxion : EPAR - Scientific Discussion